Redpin Therapeutics

graphic of the brain and the electrical signals that make it up
Biotech

Kriya buys Redpin to chart gene therapy course in neurology

Kriya is buying up Redpin Therapeutics for an undisclosed amount, an initial building block for the North Carolina biotech's neurology ambitions.
Max Bayer Nov 16, 2022 11:51am
New York

Redpin bags A round to advance Chantix-controlled gene therapies

Mar 25, 2020 7:00am